Konstantinos Papadopoulos’ Post

#PIONEER+ and the #UroEvidenceHub 💙 Nice interview with James N'Dow and Thomas Abbott on PIONEER - Big Data in Prostate Cancer sustainability plan!! 🚀 👇👇🫶

📰 Year in Review: 2023 - A Year of Growth and Partnerships 🌟 As we wrap up the year, let's reflect on 2023—a year marked by growth and exciting new partnerships. Our latest blog delves into the milestones, collaborations, and strides we've made in advancing our mission. https://lnkd.in/eAzVZTjd #YearInReview #Growth #NewPartnerships

An interview about the diagnosis of pancreatic cancer with Sabina, a patient of MOÚ 🎗 We would like to share an inspiring video that emphasizes the importance of a human approach to cancer patients and early prevention. Mrs. Sabina speaks very openly about her illness and her experiences with examinations and treatment at the MASARYKŮV ONKOLOGICKÝ ÚSTAV (MOÚ) in Brno. Prevention is crucial and 🔦 early detection of cancer can save lives. 📖Education, regular preventive check-ups and early response to warning signs are essential to ensure the health and well-being of us all. The conversation with Mrs. Sabina makes us realize that, in addition to the treatment itself, it is important for patients to feel supported and cared for, not only by the family, but also by the entire team of medical professionals 👨⚕️ Together, we can work to create an environment where the human approach to patients is a priority and where prevention is the foundation of our healthcare system. We wish Mrs. Sabina a recovery from this terrible disease and may she never lose her wonderful positive attitude toward life and her illness! 🔬 Our goal is also to contribute to the early detection of pancreatic cancer with our LDPC lipidomic test and the upcoming clinical performance study, which should be launched in the second half of this year after the approval of the State Institute for Drug Control. You can check your risk of pancreatic cancer using the questionnaire on our website. in czech: https://lnkd.in/etFzpbFZ in english: https://lnkd.in/e5aFmjZG   #PancreaticCancer #Oncology #HumanAccess #Prevention https://lnkd.in/enyEPiAA

Mission Accomplished. A 15-year journey. https://lnkd.in/eg_HwZA3

I am implementing a, "system that we can very rapidly with minimal cost discover high quality antibodies that can be used for molecular diagnostics. Learn more about our antibody discovery technologies from Staff Scientist Justin Layer.

🟡 Mozart Therapeutics, Inc Raises $25M in Series A Extension for Autoimmune Disease Treatments 🩺 The company focuses on the development of CD8 Treg Modulators for the treatment of autoimmune and inflammatory diseases. Under the leadership of Katie Fanning, the President & CEO, Mozart Therapeutics, Inc has made significant strides in advancing novel therapies for addressing these complex conditions. The funding round featured the participation of notable investors, including Pfizer Ventures LLC, AbbVie Ventures, Ono Venture Investment, and UPMC Enterprises, among others. Their support signifies the recognition of Mozart Therapeutics' innovative approach to tackling autoimmune diseases. This substantial funding achievement highlights the growing importance of developing effective treatments for autoimmune and inflammatory conditions. Mozart Therapeutics' commitment to improving patients' lives through their CD8 Treg Modulators deserves commendation. To stay informed about the latest advancements in female-focused business and tech news, sign up for The Circle Back daily newsletter. #WomenInBusiness #WomenInTech #StartupSuccess #AutoimmuneDiseases #Healthcare

A very enjoyable discussion with Paul Hill this morning on my journey so far with Oncimmune, our new strategy and progress against that as well as the market as a whole and what the future may bring. #Immunoinsights #Oncimmune #immunooncology #autoimmunedisease